Correction to: Baseline plasma KL-6 level predicts adverse outcomes in patients with idiopathic pulmonary fibrosis receiving nintedanib: a retrospective real-world cohort study.

Huang, Tang-Hsiu; Kuo, Chin-Wei; Chen, Chian-Wei; Tseng, Yau-Lin; Wu, Chao-Liang; Lin, Sheng-Hsiang

Huang, Tang-Hsiu; Kuo, Chin-Wei; Chen, Chian-Wei; Tseng, Yau-Lin; Wu, Chao-Liang; Lin, Sheng-Hsiang.

Afiliação

Huang TH; Division of Chest Medicine, Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
Kuo CW; Institute of Clinical Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
Chen CW; Division of Chest Medicine, Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
Tseng YL; Institute of Clinical Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
Wu CL; Division of Chest Medicine, Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
Lin SH; Division of Thoracic Surgery, Department of Surgery, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.

BMC Pulm Med ; 21(1): 193, 2021 Jun 08.

Article em En | MEDLINE | ID: mdl-34103038

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: BMC Pulm Med Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Taiwan

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google